Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 332 followers

Latest posts

Last updated about 6 hours ago

Human medicines European public assessment report (EPAR): Byannli (previously Paliperidone Janssen-Cilag International), paliperidone, Date of authorisation: 18/06/2020, Revision: 5, Status: Authorised

about 7 hours ago

Human medicines European public assessment report (EPAR): Byannli (previously Paliperidone Janssen-Cilag International)...

Human medicines European public assessment report (EPAR): Oczyesa, octreotide, Date of authorisation: 30/06/2025, Revision: 2, Status: Authorised

about 7 hours ago

Human medicines European public assessment report (EPAR): Oczyesa, octreotide, Date of authorisation...

Human medicines European public assessment report (EPAR): Vargatef, nintedanib, Date of authorisation: 21/11/2014, Revision: 22, Status: Authorised

about 7 hours ago

Human medicines European public assessment report (EPAR): Vargatef, nintedanib, Date of authorisation...

Human medicines European public assessment report (EPAR): Crysvita, burosumab, Date of authorisation: 19/02/2018, Revision: 18, Status: Authorised

about 7 hours ago

Human medicines European public assessment report (EPAR): Crysvita, burosumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 17, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation...

Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 29, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation...

Human medicines European public assessment report (EPAR): Slenyto, melatonin, Date of authorisation: 20/09/2018, Revision: 15, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Slenyto, melatonin, Date of authorisation...

Human medicines European public assessment report (EPAR): Upstaza, eladocagene exuparvovec, Date of authorisation: 18/07/2022, Revision: 10, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Upstaza, eladocagene exuparvovec, Date of...

Human medicines European public assessment report (EPAR): Bysumlog, insulin lispro, Date of authorisation: 06/05/2026, Status: Authorised

about 9 hours ago

Human medicines European public assessment report (EPAR): Bysumlog, insulin lispro, Date of...

List of eligible industry stakeholder organisations

about 9 hours ago

List of eligible industry stakeholder organisations

EMA/HMA European platform for regulatory science research platform meeting – draft agenda

about 12 hours ago

EMA/HMA European platform for regulatory science research platform meeting – draft agenda